Rhenman & Partners Asset Management AB Acquires 24,230 Shares of Humana Inc. (NYSE:HUM)

Rhenman & Partners Asset Management AB raised its holdings in Humana Inc. (NYSE:HUM) by 78.2% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 55,230 shares of the insurance provider’s stock after buying an additional 24,230 shares during the quarter. Humana accounts for 1.4% of Rhenman & Partners Asset Management AB’s investment portfolio, making the stock its 28th largest holding. Rhenman & Partners Asset Management AB’s holdings in Humana were worth $14,012,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently modified their holdings of the business. Transcend Capital Advisors LLC lifted its holdings in shares of Humana by 399.7% in the 4th quarter. Transcend Capital Advisors LLC now owns 3,643 shares of the insurance provider’s stock worth $924,000 after purchasing an additional 2,914 shares in the last quarter. FNY Investment Advisers LLC lifted its stake in shares of Humana by 6,647.5% in the fourth quarter. FNY Investment Advisers LLC now owns 27,260 shares of the insurance provider’s stock valued at $6,916,000 after buying an additional 26,856 shares in the last quarter. Retirement Systems of Alabama lifted its stake in shares of Humana by 735.9% in the fourth quarter. Retirement Systems of Alabama now owns 219,002 shares of the insurance provider’s stock valued at $55,563,000 after buying an additional 192,801 shares in the last quarter. Charles Schwab Investment Management Inc. grew its holdings in shares of Humana by 7.3% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 964,926 shares of the insurance provider’s stock valued at $244,811,000 after buying an additional 65,735 shares during the last quarter. Finally, Secure Asset Management LLC bought a new stake in shares of Humana during the fourth quarter worth about $244,000. 92.38% of the stock is currently owned by institutional investors.

Humana Trading Down 4.6 %

Shares of NYSE HUM opened at $253.37 on Friday. The stock has a market capitalization of $30.58 billion, a P/E ratio of 25.46, a PEG ratio of 2.05 and a beta of 0.62. Humana Inc. has a 1-year low of $213.31 and a 1-year high of $406.46. The business’s 50 day moving average is $267.58 and its two-hundred day moving average is $272.13. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.76 and a quick ratio of 1.76.

Humana (NYSE:HUM) last released its quarterly earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) EPS for the quarter, topping analysts’ consensus estimates of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. As a group, research analysts expect that Humana Inc. will post 16.47 EPS for the current year.

Humana Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be given a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.40%. The ex-dividend date is Friday, March 28th. Humana’s dividend payout ratio (DPR) is presently 35.58%.

Wall Street Analyst Weigh In

HUM has been the topic of a number of analyst reports. StockNews.com downgraded shares of Humana from a “buy” rating to a “hold” rating in a report on Tuesday, March 18th. Morgan Stanley cut their price target on shares of Humana from $301.00 to $285.00 and set an “equal weight” rating on the stock in a report on Wednesday, February 12th. Piper Sandler upped their price objective on shares of Humana from $270.00 to $288.00 and gave the stock a “neutral” rating in a research report on Wednesday, January 15th. JPMorgan Chase & Co. dropped their target price on shares of Humana from $257.00 to $256.00 and set a “neutral” rating on the stock in a research report on Tuesday, February 18th. Finally, Truist Financial boosted their target price on Humana from $260.00 to $290.00 and gave the stock a “hold” rating in a research note on Monday, January 6th. Eighteen research analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $280.17.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.